作者: A.V. Kabanov , H.E. Gendelman
DOI: 10.1016/J.PROGPOLYMSCI.2007.05.014
关键词: Disease 、 Disease outcome 、 Stroke 、 Population 、 Nanostructured materials 、 Nanomedicine 、 Degenerative disease 、 Intensive care medicine 、 Medicine 、 Amyotrophic lateral sclerosis
摘要: Neurodegenerative and infectious disorders including Alzheimer's Parkinson's diseases, amyotrophic lateral sclerosis, stroke are rapidly increasing as population's age. disease alone currently affects 4.5 million Americans, more than $100 billion is spent per year on medical institutional care for affected people. Such numbers will double in the ensuing decades. Currently diagnosis all made, large measure, clinical grounds laboratory neuroimaging tests confirm what seen by routine examination. Achieving early would enable improved outcomes. Drugs, vaccines or regenerative proteins present "real" possibilities positively affecting outcomes, but limited that their entry into brain commonly restricted across blood-brain barrier. This review highlights how these obstacles can be overcome polymer science nanotechnology. approaches may improve diagnostic therapeutic New developments coupled with cell-based delivery strategies support notion diseases now have options show outcomes advances nanomedicine.